Skip to main content

Hematologic Tests

0
Pipeline Programs
2
Companies
4
Clinical Trials
0
Approved Products

Pipeline by Development Stage

Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
0
0
0
0
0
0
Early DiscoveryClinical DevelopmentMarket

Competitive Landscape

2 companies ranked by most advanced pipeline stage

Abbott
AbbottABBOTT PARK, IL
2 programs
Blood drawN/A1 trial
Capillary blood drawN/A2 trials
Active Trials
NCT07287618Completed425Est. Aug 2026
NCT07908056Not Yet Recruiting425Est. Oct 2027
NCT07287631Completed425Est. Aug 2026
Essenlix
EssenlixNJ - Monmouth Junction
1 program
iMOST X-1 Hematology AnalyzerN/A1 trial
Active Trials
NCT04778553Completed60Est. Jan 2021

Trial Timeline

Clinical trial activity over time

2021
2022
2023
2024
2025
2026
2027
AbbottCapillary blood draw
AbbottCapillary blood draw
AbbottBlood draw
EssenlixiMOST X-1 Hematology Analyzer

Clinical Trials (4)

Total enrollment: 1,335 patients across 4 trials

NCT07908056AbbottCapillary blood draw

Evaluate Precision of the Test for Lactate in Capillary Whole Blood Specimens Using the i-STAT CG4+ Cartridge With the i-STAT 1 Analyzer

Start: Oct 2026Est. completion: Oct 2027425 patients
N/ANot Yet Recruiting
NCT07287631AbbottCapillary blood draw

Clinical Evaluation of Precision for the Potassium and Ionized Calcium Tests in Capillary Specimens

Start: Sep 2025Est. completion: Aug 2026425 patients
N/ACompleted
NCT07287618AbbottBlood draw

Evaluation of Potassium (K) and Ionized Calcium (iCa) Tests Using Capillary Specimens

Start: Sep 2025Est. completion: Aug 2026425 patients
N/ACompleted
NCT04778553EssenlixiMOST X-1 Hematology Analyzer

Clinical Evaluation of the iMOST-X1 Hematology Analyzer - Matrix Study

Start: Oct 2020Est. completion: Jan 202160 patients
N/ACompleted

Phase Legend

Preclinical— Lab & animal studies
Phase 1— Safety & dosing
Phase 2— Efficacy testing
Phase 3— Large-scale trials
On Market— Approved & available

Key Insights

2 companies competing in this space

The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.